These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 16513836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone.
    Asou Y, Rittling SR, Yoshitake H, Tsuji K, Shinomiya K, Nifuji A, Denhardt DT, Noda M.
    Endocrinology; 2001 Mar; 142(3):1325-32. PubMed ID: 11181551
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
    Yates AJ, Oreffo RO, Mayor K, Mundy GR.
    J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Osteopontin deficiency enhances anabolic action of EP4 agonist at a sub-optimal dose in bone.
    Kato N, Kitahara K, Rittling SR, Nakashima K, Denhardt DT, Kurosawa H, Ezura Y, Noda M.
    J Endocrinol; 2007 Apr; 193(1):171-82. PubMed ID: 17400814
    [Abstract] [Full Text] [Related]

  • 11. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
    Razzouk S, Brunn JC, Qin C, Tye CE, Goldberg HA, Butler WT.
    Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563
    [Abstract] [Full Text] [Related]

  • 12. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
    Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J.
    J Bone Miner Res; 2002 Aug; 17(8):1486-97. PubMed ID: 12162503
    [Abstract] [Full Text] [Related]

  • 13. Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency.
    Shapses SA, Cifuentes M, Spevak L, Chowdhury H, Brittingham J, Boskey AL, Denhardt DT.
    Calcif Tissue Int; 2003 Jul; 73(1):86-92. PubMed ID: 14506959
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo.
    Morinobu M, Ishijima M, Rittling SR, Tsuji K, Yamamoto H, Nifuji A, Denhardt DT, Noda M.
    J Bone Miner Res; 2003 Sep; 18(9):1706-15. PubMed ID: 12968681
    [Abstract] [Full Text] [Related]

  • 16. The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts.
    Rajachar RM, Truong AQ, Giachelli CM.
    J Mater Sci Mater Med; 2008 Oct; 19(10):3279-85. PubMed ID: 18483788
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adenoviral down-regulation of osteopontin inhibits human osteoclast differentiation in vitro.
    Aitken CJ, Hodge JM, Nicholson GC.
    J Cell Biochem; 2004 Nov 15; 93(5):896-903. PubMed ID: 15389974
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.